128 related articles for article (PubMed ID: 16523921)
1. [IgA nephropathy--pathogenesis, pathophysiology, and therapy].
Narita I; Goto S; Kondo D; Sakatsume M; Gejyo F
Nihon Rinsho; 2006 Feb; 64 Suppl 2():397-402. PubMed ID: 16523921
[No Abstract] [Full Text] [Related]
2. [IgA nephropathy].
Tomino Y
Nihon Rinsho; 2005 May; 63 Suppl 5():516-20. PubMed ID: 15954402
[No Abstract] [Full Text] [Related]
3. Modulating the progression in IgA nephropathy.
Chan JC; Trachtman H
Nephron Clin Pract; 2006; 104(1):c61-8. PubMed ID: 16741372
[TBL] [Abstract][Full Text] [Related]
4. IgA nephropathy treatment 25 years on: can we halt progression? The evidence base.
Ballardie FW
Nephrol Dial Transplant; 2004 May; 19(5):1041-6. PubMed ID: 15102965
[No Abstract] [Full Text] [Related]
5. Immune complex formation in IgA nephropathy: CD89 a 'saint' or a 'sinner'?
Boyd JK; Barratt J
Kidney Int; 2010 Dec; 78(12):1211-3. PubMed ID: 21116273
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenesis of Berger's disease: recent advances on the involvement of immunoglobulin A and their receptors].
Monteiro RC; Leroy V; Launay P; Moura IC; Arcos-Fajardo M; Benhamou M; Haddad E
Med Sci (Paris); 2003 Dec; 19(12):1233-41. PubMed ID: 14691748
[TBL] [Abstract][Full Text] [Related]
7. Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells.
Leung JCK; Tsang AWL; Chan DTM; Lai KN
J Am Soc Nephrol; 2000 Feb; 11(2):241-249. PubMed ID: 10665931
[TBL] [Abstract][Full Text] [Related]
8. IgA nephropathy.
Wardle EN
N Engl J Med; 2003 Jan; 348(1):79-81; author reply 79-81. PubMed ID: 12510692
[No Abstract] [Full Text] [Related]
9. [Update in primary glomerular diseases--mainly in IgA nephropathy].
Kawamura T
Nihon Jinzo Gakkai Shi; 2002 Oct; 44(7):514-23. PubMed ID: 12476587
[No Abstract] [Full Text] [Related]
10. The treatment of IgA nephropathy: status at the end of the millenium.
Glassock RJ
J Nephrol; 1999; 12(5):288-96. PubMed ID: 10630691
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin A nephropathy: fish oils and beyond.
Feehally J
Curr Opin Nephrol Hypertens; 1996 Sep; 5(5):442-6. PubMed ID: 8937814
[TBL] [Abstract][Full Text] [Related]
12. The CARI guidelines. Prevention of progression of kidney disease.
Harris D; Thomas M; Johnson D; Nicholls K; Gillin A;
Nephrology (Carlton); 2006 Apr; 11 Suppl 1():S2-197. PubMed ID: 16684077
[No Abstract] [Full Text] [Related]
13. Dysfunctions of Fc alpha receptors by blood phagocytic cells in IgA nephropathy.
Monteiro RC; Grossetête B; Nguyen AT; Jungers P; Lehuen A
Contrib Nephrol; 1995; 111():116-22. PubMed ID: 7538927
[No Abstract] [Full Text] [Related]
14. Advances in treatment: immunoglobulin A nephropathy.
Hogg RJ; Waldo B
Semin Nephrol; 1996 Nov; 16(6):511-6. PubMed ID: 9125795
[TBL] [Abstract][Full Text] [Related]
15. Fc(alpha)/mu receptor is a single gene-family member closely related to polymeric immunoglobulin receptor encoded on Chromosome 1.
Shimizu Y; Honda S; Yotsumoto K; Tahara-Hanaoka S; Eyre HJ; Sutherland GR; Endo Y; Shibuya K; Koyama A; Nakauchi H; Shibuya A
Immunogenetics; 2001 Oct; 53(8):709-11. PubMed ID: 11797105
[No Abstract] [Full Text] [Related]
16. IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors.
Locatelli F; Vecchio LD; Pozzi C
Nat Clin Pract Nephrol; 2006 Jan; 2(1):24-31. PubMed ID: 16932386
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of IgA nephropathy.
Feehally J; Allen AC
Ann Med Interne (Paris); 1999 Feb; 150(2):91-8. PubMed ID: 10392257
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in the promoter and 5' UTR region of the Fc alpha receptor (CD89) are not associated with a risk of IgA nephropathy.
Narita I; Goto S; Saito N; Sakatsume M; Jin S; Omori K; Gejyo F
J Hum Genet; 2001; 46(12):694-8. PubMed ID: 11776381
[TBL] [Abstract][Full Text] [Related]
19. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Eto T; Nakao H
Ren Fail; 2005; 27(1):45-52. PubMed ID: 15717634
[TBL] [Abstract][Full Text] [Related]
20. Therapy of patients with IgA-nephropathy: a critical appraisal.
Floege J; Mertens P
Kidney Blood Press Res; 2000; 23(3-5):207-9. PubMed ID: 11031723
[No Abstract] [Full Text] [Related]
[Next] [New Search]
